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This year marks the centenary of Robert Koch’s Nobel
Prize for discovering the cause of tuberculosis. Koch
was also the first scientist to isolate the anthrax and
cholera microbes. Yet perhaps one of his greatest
contributions to biology is the least appreciated: his
method for propagating individual colonies of bacte-
ria on plates, a technique that came to be called
cloning.
As Barry Marshall and Robin Warren are set to collect
the 2005 Nobel Prize in Physiology or Medicine next
month for “their discovery of the bacterium Helico-
bacter pylori and its role in gastritis and peptic ulcer
disease,” it is apposite to recall that exactly 100 years
earlier Robert Koch traveled from Berlin to Stockholm
to receive his Nobel Prize for “investigations and dis-
coveries in relation to tuberculosis.” Koch’s achieve-
ments in identifying other pathogens, such as anthrax
and cholera, were equally remarkable. Yet his most
original contribution to basic biology is the method he
devised in 1881 for propagating single colonies of bac-
teria on plates, a technique that we would now call
cloning. This method led to the second of his famous
postulates for identifying the cause of an infectious dis-
ease: that the microbe must be isolated in pure form.
Since then, many scientists have made major discover-
ies by adapting the cloning technology developed by
Koch. From DNA cloning to monoclonal antibodies and
even cloning whole organisms, such advances have
helped to spawn at least six more Nobel Prizes.
Koch and His Postulates
Robert Koch (1843–1910) (Figure 1) was a German sci-
entist without mentors in research (Brock, 1999). He be-
gan his microbiological investigations as a hobby soon
after his appointment in 1872 as a distinct physician in
Wollstein (now Wolsztyn in Poland). He laid the ground-
work for his great contributions there, moving to Berlin
in 1880. As early as 1873, from examining a sheep that
had died from anthrax, he proposed that the cause of
this disease was rod-shaped “bacilli” that differentiated
into long-lived round spores. Louis Pasteur was already
advocating the germ theory of disease and was quick
to develop an anthrax vaccine following Koch’s dis-
covery.
In 1840, Jacob Henle first conceptualized the source
of a contagion as being a living agent, with his famous
dictum: “It is not the disease which is being transferred*Correspondence: r.weiss@ucl.ac.ukFigure 1. Robert Koch in 1884 (Courtesy of the Robert Koch In-
stitute)but the cause of the disease.” But a generation later,
Rudolf Virchow in Berlin, Max von Pettenkofer in Mu-
nich, and Theodor Billroth in Vienna still doubted the
key role of micro-organisms in infectious disease.
The postulates for which Koch is chiefly remembered
today are something of a misnomer because he never
clearly enunciated them himself, although he followed
their logic in pathogen discovery. It was Edwin Klebs,
Professor of Pathology in Prague and a keen champion
of Henle’s ideas, who hinted at Koch’s postulates in
1875: careful microscopic study of the diseased organ,
culture of the germ associated with the disease, and
production of the same disease by inoculation of this
cultured germ into healthy animals. Klebs also re-
phrased Henle’s aphorism to: “It is not the disease, but
the cause of the disease, that reproduces.”
The version of Koch’s postulates most frequently
cited was ascribed to Koch by his research assistant,
Friedrich Loeffler, in his 1883 paper identifying Coryne-
bacterium diphtheriae as the cause of diphtheria.
(1) The microbe must be consistently shown to be
present in the diseased tissue and not in healthy
tissue;
(2) The microbe must be isolated and grown in cul-
ture in pure form;
(3) The pure culture must be shown to induce the dis-
ease anew.
Pasteur and Koch
Pasteur and Koch ought to have stood shoulder to
shoulder in promoting the germ theory of contagious
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spent more energy attacking each other. Initially Louis
Pasteur treated the younger Koch with haughty disdain;
meanwhile Koch attacked Pasteur’s studies on anthrax.
Joseph Lister’s diplomacy in bringing the two together in
London in 1881 did little to defuse their antagonism.
Pasteur focused on treating individuals by immunization,
whereas Koch’s venture into this field with tuberculin
(PPD) was a disaster; his strengths lay in pathogen dis-
covery and prevention through sanitation. Doubtless their
rivalry was fueled by nationalist feelings in the aftermath
of the Franco-Prussian war. Pasteur himself wrote “La
science n’a pas de patrie, mais le savant doit en avoir
une” (Science has no fatherland, but the scientist must
have one).
Koch and Pasteur not only bequeathed to us the ma-
jor principles of microbiology but also the institutes that
carry out leading research to this day. Last month the
Robert Koch Institute in Berlin held a symposium on
“Challenges Posed by Infectious Diseases on the 100th
Anniversary of Robert Koch’s Nobel Prize Award”; tu-
berculosis, alas, was still among them. Two of Koch’s
former assistants themselves won Nobel Prizes for
Medicine: Emil von Behring in 1901 (who won the first
Prize) for developing antitoxins and Paul Ehrlich in 1908
for developing chemotherapy.
Bacterial Cloning
Why should I call Robert Koch the “grandfather of clon-
ing”? It is on account of his 1881 paper “Zur Unter-
suchung von Pathogenen Organismen” (On the Exami-
nation of Pathogenic Organisms) in which he describes
a method for growing isolated colonies of bacteria. He
poured a hot mixture of nutrient broth and gelatin onto
a glass plate, which was then allowed to set before
exposing it to germs. He described how separate colo-
nies developed that eventually merged into a microbial
film. This method allowed him to pick cells from indi-
vidual colonies and to propagate them as “pure” cul-
tures. He could then test their pathogenicity by inocu-
lation into experimental animals. He recognized that
different colonies have different morphologies yet
breed true on propagation, and he adopted a Linnean
nomenclature for bacterial species (Schlich, 2000).
Koch’s cloning technique did not come out of the
blue. In 1875, Joseph Schroeter had observed discrete,
red colonies of the bacterium Serratia marcescens on
the cut surface of potatoes. Although Koch did not cite
Schroeter, he stated that seeing different types of col-
ony growing on potato slices led him to develop the
gelatin plate technique. In 1878, Joseph Lister de-
scribed the limiting dilution method in liquid culture for
isolating bacteria in pure form, but Koch exploited bulk
culture for the progeny of his clones.
Two further developments in the 1880s established
microbiological cloning essentially as we know it today,
namely the use of agar as a semi-solid nutrient medium
suggested in 1882 by Fannie Hesse (a practical “haus-
frau” and a laboratory assistant) and the introduction
of the petri dish (Figure 2A). In 1887, Koch’s protégé,
Richard Petri, described “A small modification of
Koch’s plate technique” as his paper was titled (in Ger-
man). He wrote:
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higure 2. Clones that Koch Would Recognize
A) Colonies of E. coli on agar in a Petri dish. White clones contain
ecombinant DNA, whereas blue clones are wild-type (S. Nambulli
nd I. Harrison, Wohl Virion Centre).
B) Polio virus plaques in a monolayer of HeLa cells under agar
courtesy of J.E. Darnell, Jr).
C) Rous sarcoma virus assay on a monolayer of quail embryo fi-
roblasts and (D) scanning electron micrograph of a transformed
lone (R.A. Weiss, 1969, PhD thesis, University of London).
E) Cloning of human HeLa cells by T.T. Puck, P.I. Marcus, and S.J.
ieciura and (F) individual clone showing epithelial morphology (re-
roduced from The Journal of Experimental Medicine (1956). 103,
73–283 by copyright permission of the Rockefeller University
ress).I have been using flat double dishes of 10–11 cm wide and
1–1.5 cm high. The larger diameter dish serves as a lid.
These dishes are sterilized by dry heat. After cooling, the
upper dish is lifted only slightly and nutrient gelatin is
poured in… These dishes are especially recommended for
agar-agar plates, since agar-agar sticks poorly to flat glass
plates. In addition it is quite simple to count the colonies
after they have grown by replacing the lid with a glass plate
with squares etched on it viewed over a black background.
Petri’s name lives on from this one and only notable
ontribution.
loning since Koch
he word cloning today conjures up images of Dolly
he sheep or the contentious ethics of human cloning
Klotzko, 2004). Yet back in 1975, it was the potential
azard of recombinant DNA cloning that was hotly de-
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541bated at the Asilomar conference. In the same year,
Koehler and Milstein published their seminal paper on
monoclonal antibodies, made possible by fusing anti-
body-producing B lymphocytes with immortal myeloma
cells. But where did the concept of cloning come from,
be it DNA, cells, or whole organisms? When was the
term introduced and what is its origin?
I had imagined that the etymology of clone was a
corruption of colony, but it is actually derived from the
Greek, klon, meaning a twig or small branch. This ety-
mology reveals the original use of the word clone to
describe vegetative reproduction of plants by taking
cuttings. Because higher plants, unlike animals, do not
sequester a germline distinct from somatic cells, plant
cells remain pluripotent; reproductive cloning of plants,
for example potatoes, occurs naturally and has been
practiced for millennia by horticulturists in the propaga-
tion of vines and fruit trees. The new plants derived
from cuttings or grafts are genetically identical to the
parent, and the term clone came to be used for any
form of artificial, asexual means of replication.
Although the word clone was introduced botanically
in 1903, the first use that I have found to describe repli-
cation from a single progenitor was in 1954 when Theo-
dore T. Puck and colleagues cloned human cells in cul-
ture. However, the word clone did not appear in general
dictionaries until later. My 1964 Oxford Concise Dictio-
nary restricts the definition to “a group of plants repro-
duced vegetatively from one original seedling or stock,”
whereas my wife’s 1992 Chambers Pocket Dictionary
gives two meanings: (1) (anyone of) a group of identical
organisms reproduced by a non-sexual process from a
single cell of the parent; (2) (colloq. or derog.) a person
or thing that looks like a replica of someone or some-
thing else. The “single-cell” restriction in Chambers im-
plies that it no longer refers to vegetative propagation
of plants.
If Koch is the grandfather of cloning, who is the fa-
ther? I would regard the parents of cloning to be the
founders of microbial genetics. The heritable trans-
formation of a bacterial phenotype by Fred Griffith in
1928 led directly to the identification of the genetic
material as DNA by Oswald Avery, Maclyn McCarty, and
Colin MacLeod in 1944. The study of bacterial genetics
through the selection of colonies and of bacteriophage
genetics by picking plaques launched molecular biol-
ogy. This new field gained tremendous impetus from
the Nobel laureates Max Delbruck, Alfred Hershey,
Joshua Lederberg, Salvador Luria, and André Lwoff
(Judson, 1996). The culmination of microbial genetics
was the invention of DNA cloning (see below). Koch’s
biological cloning method for bacteria also led to
studies of mutation, DNA repair, and antibiotics. What
else was Alexander Fleming’s seminal observation
other than inhibition of bacterial colonies by a contami-
nating mold in a discarded petri dish?
Cloning Viruses
In 1917, F. d’Herelle grew bacteriophage on a lawn of
Shigella bacteria in a petri dish for 50 successive pas-
sages; in calculating a titer of over 109, he described
clear 1 mm diameter plaques. This heralded the cloning
of viruses. Plant viruses could be plaque titrated onleaves, but a problem remained for animal viruses,
which had to be grown by inoculation into animals or
eggs. The first cloning technique for animal viruses was
achieved by infecting the chorio-allantoic membrane
(CAM) of fertile chick eggs. This is the membrane just
under the shell that serves as the embryo’s “lung.” In
1936, E.V. Keogh used CAM assays to titrate and clone
vaccinia virus, and in 1938 he developed a quantitative
CAM assay for Rous sarcoma virus.
It was not until the trypsinization of embryonic cells
was developed in 1952 that the animal cell equivalent
to a lawn of bacteria became available. Renato Dul-
becco immediately took advantage of the technique to
plate pathogens such as Western equine encephalitis
and polio viruses on dispersed cell monolayers. Again
agar medium, this time as an overlay to keep lytic
plaques discrete (Figure 2B), enabled cloning through
recovery of the viral progeny with a pipette. Cell trans-
formation in monolayer culture by oncogenic viruses
was achieved in 1955 by Dulbecco for the polyoma
virus, for which he received the 1975 Nobel Prize (with
David Baltimore and Howard M. Temin, who discovered
reverse transcriptase in 1970). In 1958, Temin and Harry
Rubin, working in Dulbecco’s laboratory, used chick
embryo cell monolayers to develop a quantitative assay
of cell transformation by Rous sarcoma virus (Figures
2C and 2D).
These lytic and transformation techniques opened
the way to animal virus genetics and the discovery of
oncogenes. More recently, viral pathogens that could
not be cultured in the laboratory were discovered
through recombinant DNA and cDNA cloning, for exam-
ple hepatitis C virus in 1989 and Kaposi’s sarcoma her-
pesvirus in 1994.
Mammalian Cell Cloning
Immortal cell lines were developed from the late 1940s.
Mouse L cells were first cloned by Earle in 1948 through
single-cell isolation in capillary tubes, and human HeLa
cells isolated by G. Gey in 1952 were cloned by Theo-
dore Puck (Figures 2D and 2E). In the 1960s, nontrans-
formed cell lines with a high cloning efficiency (such as
hamster BHK21 and mouse 3T3 cells) were developed
and used to select transformed colonies after exposure
to oncogenic viruses or other carcinogenic agents.
Now that cells could be grown as colonies like bacte-
ria, the science of mammalian somatic cell genetics
blossomed (Harris, 1997) and was a boon to the fields
of radiobiology and mutagenesis. Fusion of cells of dif-
ferent parentage allowed analysis of chromosome seg-
regation and genetic mapping. Just as Koch labored to
find a suitable medium to grow tubercle bacilli in 1882,
mammalian cell culture required meticulous studies by
Puck and Harry Eagle to establish optimal media for
cloning. We still use DMEM (Dulbecco-modified Eagle’s
medium) with 10% fetal calf serum, which was devel-
oped nearly 50 years ago to afford 100% cloning effi-
ciency of HeLa cells.
Monoclonal Antibodies and Reproductive Cloning
Perhaps the most famous example of exploiting the im-
mortal, clonable properties of tumor cells is the deriva-
tion in 1975 of monoclonal antibodies by Georges
Cell
542Koehler and Cesar Milstein, who were awarded the No-
bel Prize for this discovery in 1984. By fusing a my-
eloma cell with a primary B lymphocyte, they created a
cloned “hybridoma” that secreted a specific antibody.
Myeloma cells had to be used for immortalization be-
cause they are differentiated plasma cells, whereas fu-
sion of somatic cells of different types tends to extin-
guish expression of lineage-specific genes.
The restriction to mammalian gene expression has
now been overcome by nuclear transfer into eggs or
pluripotent embryonic stem cells, which had its birth in
the successful transfer of embryo cell nuclei into frog
eggs by R. Briggs and T. King in 1952. This resetting
of the transcriptome makes possible reproductive and
therapeutic cloning. These techniques hold great prom-
ise but require considerable debate to ensure that they
are not misused (Klotzko, 2004).
Recombinant DNA and Clonal Amplification
The universality of the genetic code means that DNA
can function in any biological setting. This was power-
fully exploited by introducing DNA from different
sources (e.g., human DNA) into viruses or bacterial
plasmids, which were then clonally propagated. Thus,
the practice of recombinant DNA cloning was born in
1972–1973 through the pioneering investigations of
Paul Berg (a Nobel laureate), Stanley Cohen, and Herb
Boyer using restriction enzymes and DNA ligation. DNA
cloning has, of course, revolutionized molecular biol-
ogy and the pharmaceutical industry (Figure 2A).
When the possibilities of DNA cloning first became
apparent, however, the leading molecular biologists
themselves expressed concern that exchanging ge-
netic information between quite unrelated organisms
posed a potential biological hazard. They convened a
conference at Asilomar in California in March 1975,
which resulted in a voluntary moratorium on DNA clon-
ing until the possible risks could be more precisely as-
sessed. No apparent harm has emerged from DNA
cloning, and we now know that horizontal transfer of
DNA and plasmids frequently occurs in nature.
The PCR revolution led to the award of a chemistry
Nobel prize to Kary Mullis in 1993. The polymerase
chain reaction allows the clonal amplification of spe-
cific DNA sequences resulting in millions of copies. This
version of cloning has transformed diagnostic tech-
niques including forensic science. Short synthetic yet
specific DNA sequences are also the stuff of DNA
microarrays. Indeed, the promise of DNA microchips in
computers illustrates the increasingly sophisticated
miniaturization of cloning technology.
If Koch Were Here Today?
What might Koch have thought of modern medical
technologies? He would immediately recognize an
E. coli cloning dish, viral plaques, and mammalian cell
cloning as direct derivatives of his and Petri’s cloning
methods (Figure 2). I imagine that he would be support-
ive of therapeutic stem cell cloning and reproductive
animal cloning yet be nonplussed (as I am) as to why
anyone should wish to clone a human.
Koch would surely delight in Marshall’s and Warren’s
2005 Nobel Prize because the identification of the bac-
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tewart Goodwin) as the cause of peptic ulcers relied
n his classical methods of isolation and his postulates.
ndeed, in the absence of an animal model, Barry de-
ided to swallow the bacteria himself and he soon de-
eloped acute gastritis. Koch would wryly recall Max
on Pettenkofer in 1892 swallowing a culture of Vibrio
holerae in an attempt to disprove its role in cholera,
iven that Koch and Georg Gaffky had first isolated the
omma-shaped pathogen in Calcutta in 1884. Thus,
obert Koch’s contributions to infectious disease and
o cloning methods resonate to this day.
cknowledgments
thank my colleagues in the Wohl Virion Centre and Christoph
radmann (University of Heidelberg) for critical comments.
eferences
rock, T.D. (1999). Robert Koch: A Life in Medicine and Bacteriol-
gy (Washington D.C.: American Society for Microbiology Press).
arris, H. (1997). The Cells of the Body: A History of Somatic Cell
enetics (Cold Spring Harbor, New York: Cold Spring Harbor Labo-
atory Press).
udson, H.F. (1996). The Eighth Day of Creation (Cold Spring Har-
or, New York: Cold Spring Harbor Laboratory Press).
lotzko, A.J. (2004). A Clone of Your Own? The Science and Ethics
f Cloning (Oxford: Oxford University Press).
chlich, T. (2000). Linking cause and disease in the laboratory:
obert Koch's method of superimposing visual and ‘functional’
epresentations of bacteria. Hist. Philos. Life Sci. 22, 43–58.
